Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin II

American Journal of Hypertension

Volumn 21, Issue 1, 2008, Pages 67-71

  Leclerc, Patrice C ^a   Proulx, Christophe D ^a   Arguin, Guillaume ^a   Bélanger, Simon ^a   Gobeil Jr , Fernand ^a   Escher, Emanuel ^a   Leduc, Richard ^a   Guillemette, Gaétan ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ASCORBIC ACID; CALCIUM ION; UNCLASSIFIED DRUG; UROTENSIN II; UROTENSIN RECEPTOR;

AORTA; ARTICLE; CALCIUM SIGNALING; CELL CULTURE; CELL STRAIN HEK293; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; MUSCLE CONTRACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RECEPTOR AFFINITY; SCATCHARD PLOT; SMOOTH MUSCLE FIBER;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; ASCORBIC ACID; CALCIUM SIGNALING; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MUSCLE, SMOOTH, VASCULAR; RABBITS; RECEPTOR, ANGIOTENSIN, TYPE 1; TIME FACTORS; TRANSFECTION; VASOCONSTRICTION;

EID: 38349095883     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2007.1     Document Type: Article

References (30)

1. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000;52:415-472.
2. Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 1999;69:1086-1107.
3. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989; 86:6377-6381.
4. Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo? Free Radic Res 1996;25:439-454.
5. Salonen JT, Salonen R, Ihanainen M, Parviainen M, Seppanen R, Kantola M, Seppanen K, Rauramaa R. Blood pressure, dietary fats, and antioxidants. Am J Clin Nutr 1988; 48:1226-1232.
6. Bates CJ, Walmsley CM, Prentice A, Finch S. Does vitamin C reduce blood pressure? Results of a large study of people aged 65 or older. J Hypertens 1998;16:925-932.
7. Ness AR, Khaw KT, Bingham S, Day NE. Vitamin C status and blood pressure. J Hypertens 1996; 14:503-508.
8. Ness AR, Chee D, Elliott P. Vitamin C and blood pressure - an overview. J Hum Hypertens 1997; 11:343-350.
9. Bulpitt CJ. Vitamin C and blood pressure. J Hypertens 1990; 8:1071-1075.
10. Duffy SJ, Gokce N, Holbrook M, Huang A, Frei B, Keaney JF Jr, Vita JA. Treatment of hypertension with ascorbic acid. Lancet 1999;354:2048-2049.
11. Mullan BA, Young IS, Fee H, McCance DR. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 2002; 40:804-809.
12. Hajjar IM, George V, Sasse EA, Kochar MS. A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids. Am J Ther 2002; 9:289-293.
13. Block G, Mangels AR, Norkus EP, Patterson BH, Levander OA, Taylor PR. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension 2001; 37:261-267.
14. Gunther S. Characterization of angiotensin II receptor subtypes in rat liver. J Biol Chem 1984; 259:7622-7629.
15. Speth RC, Rowe BP, Grove KL, Carter MR, Saylor D. Sulfhydryl reducing agents distinguish two subtypes of angiotensin II receptors in the rat brain. Brain Res 1991; 548:1-8.
16. Leclerc PC, Lanctot PM, Auger-Messier M, Escher E, Leduc R, Guillemette G. S-nitrosylation of cysteine 289 of the AT1 receptor decreases its binding affinity for angiotensin II. Br J Pharmacol 2006; 148:306-313.
17. Landino LM, Koumas MT, Mason CE, Alston JA. Ascorbic acid reduction of microtubule protein disulfides and its relevance to protein S-nitrosylation assays. Biochem Biophys Res Commun 2006; 340:347-352.
18. Guillemette G, Escher E. Analysis of the adrenal angiotensin II receptor with the photoaffinity labeling method. Biochemistry 1983; 22:5591-5596.
19. Auger-Messier M, Arguin G, Chaloux B, Leduc R, Escher E, Guillemette G. Down-regulation of inositol 1,4,5-trisphosphate receptor in cells stably expressing the constitutively active angiotensin II N111G-AT(1) receptor. Mol Endocrinol 2004; 18:2967-2980.
20. Gobeil F, Neugebauer W, Filteau C, Jukic D, Allogho SN, Pheng LH, Nguyen-Le XK, Blouin D, Regoli D. Structure-activity studies of B1 receptor-related peptides. Antagonists. Hypertension 1996; 28:833-839.
21. Poitras M, Sidibe A, Richard DE, Chretien L, Guillemette G. Effect of uncoupling agents on AT1 receptor affinity for antagonist analogs of angiotensin II. Receptors Channels 1998; 6:65-72.
22. Dudley DT, Hubbell SE, Summerfelt RM. Characterization of angiotensin II (AT2) binding sites in R3T3 cells. Mol Pharmacol 1991; 40:360-367.
23. Ullian ME, Gelasco AK, Fitzgibbon WR, Beck CN, Morinelli TA. N-acetylcysteine decreases angiotensin II receptor binding in vascular smooth muscle cells. J Am Soc Nephrol 2005; 16:2346-2353.
24. Ohyama K, Yamano Y, Sano T, Nakagomi Y, Hamakubo T, Morishima I, Inagami T. Disulfide bridges in extracellular domains of angiotensin II receptor type IA. Regul Pept 1995; 57:141-147.
25. Gryglewski RJ, Palmer RM, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-456.
26. Huie RE, Padmaja S. The reaction of no with superoxide. Free Radic Res Commun 1993; 18:195-199.
27. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998; 97:2222-2229.
28. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996; 97:22-28.
29. Hirooka Y, Eshima K, Setoguchi S, Kishi T, Egashira K, Takeshita A. Vitamin C improves attenuated angiotensin II-induced endothelium-dependent vasodilation in human forearm vessels. Hypertens Res 2003; 26:953-959.
30. Jackson TS, Xu A, Vita JA, Keaney JF Jr. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 1998; 83:916-922.